These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [A case report of two-term surgery for focal progression of a huge liver metastasis and peritoneal dissemination from gastrointestinal stromal tumor during imatinib mesylate treatment]. Toyokawa T, Teraoka H, Kitayama K, Nomura S, Kanehara I, Nishino H. Gan To Kagaku Ryoho; 2014 Mar; 41(3):373-7. PubMed ID: 24743287 [Abstract] [Full Text] [Related]
23. Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib. Lee CK, Goldstein D, Gibbs E, Joensuu H, Zalcberg J, Verweij J, Casali PG, Maki RG, Cioffi A, Mcarthur G, Lord SJ, Yip D, Kanjanapan Y, Rutkowski P. Eur J Cancer; 2015 May; 51(7):852-60. PubMed ID: 25801699 [Abstract] [Full Text] [Related]
26. [Efficacy observation on imatinib adjuvant therapy with longer duration in patients with gastrointestinal stromal at intermediate or high risk of recurrence]. Li J, Dang YZ, Gao J, Shen L. Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):216-20. PubMed ID: 23536338 [Abstract] [Full Text] [Related]
34. Surgical management of rectal gastrointestinal stromal tumors. Tielen R, Verhoef C, van Coevorden F, Reyners AK, van der Graaf WT, Bonenkamp JJ, van Etten B, de Wilt JH. J Surg Oncol; 2013 Mar; 107(4):320-3. PubMed ID: 22806955 [Abstract] [Full Text] [Related]
35. The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST). Rutkowski P, Nyckowski P, Grzesiakowska U, Nowecki ZI, Nasierowska-Guttmejer A, Pienkowski A, Dudek K, Krawczyk M, Ruka W. Neoplasma; 2003 Mar; 50(6):438-42. PubMed ID: 14689066 [Abstract] [Full Text] [Related]
36. [Surgical treatment for patients with advanced gastrointestinal stromal tumor after targeted therapy]. Wang CM, Shi YQ, Ye YW, Fu H, Zhao GF, Zhou Y, DU CY, Dong RZ. Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):155-8. PubMed ID: 19296251 [Abstract] [Full Text] [Related]
37. A multicenter long-term study of imatinib treatment for Japanese patients with unresectable or recurrent gastrointestinal stromal tumors. Ogata K, Mochiki E, Ojima H, Haga N, Fukuchi M, Aihara R, Ando H, Uchida N, Toyomasu Y, Suzuki M, Kimura A, Kogure N, Yokobori T, Ohno T, Kuwano H. J Surg Oncol; 2014 Dec; 110(8):942-6. PubMed ID: 25164620 [Abstract] [Full Text] [Related]
39. Involvement of signaling molecules in the prediction of response to imatinib treatment in metastatic GIST patients. Valadão M, Braggio D, Santos AF, Pimenta-Inada HK, Linhares E, Gonçalves R, Romano S, Vilhena B, Small I, Cubero D, Cruz F, Oliveira AT, Martinho O, Reis RM, Guimarães DP, Ferreira CG. J Surg Res; 2012 Nov; 178(1):288-93. PubMed ID: 22516345 [Abstract] [Full Text] [Related]
40. Role of metastasectomy for recurrent/metastatic gastrointestinal stromal tumors based on an analysis of the Kinki GIST registry. Sato S, Tsujinaka T, Masuzawa T, Yamamoto K, Takahashi T, Yamashita Y, Fujita J, Takagi M, Hirota S, Nishida T. Surg Today; 2017 Jan; 47(1):58-64. PubMed ID: 27194124 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]